BioTech Medics, Inc. Retains Paradigm Partners to Make $5 Million Qualifying Therapeutic Discovery Project Credit
17 June 2010 - 1:42AM
Marketwired
BioTech Medics, Inc., (PINKSHEETS: BMCS) announced today that they
have retained Paradigm National Consultants, L.P. of Houston, Texas
to determine and if qualified, prepare an application for and on
behalf of BioTech for a $5 million IRS Qualifying Therapeutic
Discovery Project Credit/Grant that was created by Congress as part
of the Patient Protection and Affordable Care Act.
Paradigm Partners plan on conducting on-site visits, collect
technical and financial documentation to substantiate qualified
activities. They will determine the involvement and contribution of
eligible employees and estimate the potential jobs that will be
created from the study and grant. Paradigm Partners has extensive
experience having performed hundreds of Research & Development
Tax Credit Studies. Paradigm's staff consists of tax consultants
and I.P. attorneys.
BioTech Medics uses two FDA 510(k) cleared high powered deep
penetrating therapeutic medical lasers to treat muscle, skeletal,
nerve and arthritis pain. Since 2003 BioTech's physicians and staff
have developed 94 proprietary protocols for various ailments such
as carpal tunnel syndrome, back ache, arthritis, sports injuries,
golfer and tennis elbow, whip lash, migraines, knee pain,
fibromyalgia, plantar fasciitis, etc. Unlike cold lasers, patients
can feel BioTech's high powered 10 and 12 watt lasers. BioTech has
a 90% success rate in reducing or eliminating pain in patients
without drugs and/or surgery.
BioTech will use the grants to prove that the use of therapeutic
lasers can save an estimated reduction of 30% or more in
medications, reduce sick days by 25% and improve recovery time by
40% with specific impairments specified in the study.
BioTech Medics owns and has affiliated BioTech Laser Pain
Management Centers in 3 states and is seeking additional
practitioners to apply to become an affiliated center in our
nationwide expansion. BioTech has clearances to expand into Canada.
BioTech is a 13 year old Nevada company with headquarters in
Irving, Texas.
Safe Harbor: Forward-Looking Statements This release contains
forward-looking statements within the meaning of The Private
Securities Litigation Reform Act of 1995 (the "Act"). Such words
like "plan" or "estimate" are indicative of forward-looking
statements. There may be "important" factors that cause actual
results to differ materially from those predicted. Such factors may
include but are not limited to the IRS denying the grant, or not
having sufficient credits to approve all applicants.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: Tom Wood Sr. V.P. 972-274-5533
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Dec 2024 to Jan 2025
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Jan 2024 to Jan 2025